Single drug biomarker prediction for ER− breast cancer outcome from chemotherapy

ER-negative breast cancer includes most aggressive subtypes of breast cancer such as triple negative (TN) breast cancer. Excluded from hormonal and targeted therapies effectively used for other subtypes of breast cancer, standard chemotherapy is one of the primary treatment options for these patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yong-Zi, Kim, Youngchul, Soliman, Hatem H, Ying, GuoGuang, Lee, Jae K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bioscientifica Ltd 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5920016/
https://www.ncbi.nlm.nih.gov/pubmed/29599124
http://dx.doi.org/10.1530/ERC-17-0495

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5920016/
https://www.ncbi.nlm.nih.gov/pubmed/29599124
http://dx.doi.org/10.1530/ERC-17-0495

Ejemplares similares